Viewing Study NCT01249820

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-06-25 @ 3:07 AM
Study NCT ID: NCT01249820
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2010-08-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease
Sponsor: Radboud University Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndrome View
None Leukemia, Myeloid, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anidulafungin View
None antifungal prophylaxis View
None allogeneic haematopoietic stem cell transplant View
None myeloablative chemotherapy View
None AML-MDS View
None pharmacokinetics View